$247 Million is the total value of Tri Locum Partners LP's 73 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WST | New | WEST PHARMACEUTICAL SVSC INC | $22,849,000 | – | 97,084 | +100.0% | 9.24% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $15,430,000 | – | 200,054 | +100.0% | 6.24% | – |
| MRK | New | MERCK & CO INC | $14,081,000 | – | 126,912 | +100.0% | 5.70% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $12,934,000 | – | 124,979 | +100.0% | 5.23% | – |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $12,117,000 | – | 99,215 | +100.0% | 4.90% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $11,474,000 | – | 221,897 | +100.0% | 4.64% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $7,659,000 | – | 26,386 | +100.0% | 3.10% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $5,374,000 | – | 141,466 | +100.0% | 2.17% | – |
| NVCR | New | NOVOCURE LTDcall | $5,311,000 | – | 72,400 | +100.0% | 2.15% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $4,901,000 | – | 684,556 | +100.0% | 1.98% | – |
| INMD | New | INMODE LTD | $4,543,000 | – | 127,242 | +100.0% | 1.84% | – |
| TGTX | New | TG THERAPEUTICS INC | $3,413,000 | – | 288,462 | +100.0% | 1.38% | – |
| RVNC | New | REVANCE THERAPEUTICS INCcall | $3,070,000 | – | 166,300 | +100.0% | 1.24% | – |
| RXDX | New | PROMETHEUS BIOSCIENCES INCcall | $2,827,000 | – | 25,700 | +100.0% | 1.14% | – |
| GH | New | GUARDANT HEALTH INCcall | $1,703,000 | – | 62,600 | +100.0% | 0.69% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCcall | $1,356,000 | – | 13,100 | +100.0% | 0.55% | – |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $889,000 | – | 17,200 | +100.0% | 0.36% | – |
| AHH | New | ARMADA HOFFLER PPTYS INC | $168,000 | – | 14,573 | +100.0% | 0.07% | – |
| AM | New | ANTERO MIDSTREAM CORP | $164,000 | – | 15,153 | +100.0% | 0.07% | – |
| WU | New | WESTERN UN CO | $153,000 | – | 11,096 | +100.0% | 0.06% | – |
| PDM | New | PIEDMONT OFFICE REALTY TR IN | $148,000 | – | 16,088 | +100.0% | 0.06% | – |
| HPP | New | HUDSON PAC PPTYS INC | $111,000 | – | 11,426 | +100.0% | 0.04% | – |
| AIV | New | APARTMENT INVT & MGMT COcl a | $101,000 | – | 14,169 | +100.0% | 0.04% | – |
| SFL | New | SFL CORPORATION LTD | $99,000 | – | 10,702 | +100.0% | 0.04% | – |
| MTW | New | MANITOWOC CO INC | $95,000 | – | 10,358 | +100.0% | 0.04% | – |
| STAR | New | ISTAR INC | $89,000 | – | 11,615 | +100.0% | 0.04% | – |
| LPRO | New | OPEN LENDING CORP | $85,000 | – | 12,661 | +100.0% | 0.03% | – |
| GPRO | New | GOPRO INCcl a | $80,000 | – | 16,062 | +100.0% | 0.03% | – |
| LL | New | LL FLOORING HOLDINGS INC | $74,000 | – | 13,185 | +100.0% | 0.03% | – |
| UNIT | New | UNITI GROUP INC | $69,000 | – | 12,491 | +100.0% | 0.03% | – |
| New | DOUGLAS ELLIMAN INC | $64,000 | – | 15,785 | +100.0% | 0.03% | – | |
| TCS | New | CONTAINER STORE GROUP INC | $65,000 | – | 15,026 | +100.0% | 0.03% | – |
| CRMD | New | CORMEDIX INC | $58,000 | – | 13,812 | +100.0% | 0.02% | – |
| EAF | New | GRAFTECH INTL LTD | $56,000 | – | 11,869 | +100.0% | 0.02% | – |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $57,000 | – | 24,147 | +100.0% | 0.02% | – |
| New | XERIS BIOPHARMA HOLDINGS INC | $49,000 | – | 36,766 | +100.0% | 0.02% | – | |
| ORGO | New | ORGANOGENESIS HLDGS INC | $50,000 | – | 18,527 | +100.0% | 0.02% | – |
| BVS | New | BIOVENTUS INC | $44,000 | – | 16,857 | +100.0% | 0.02% | – |
| AMRX | New | AMNEAL PHARMACEUTICALS INC | $43,000 | – | 21,622 | +100.0% | 0.02% | – |
| New | SOMALOGIC INC CLASS A | $42,000 | – | 16,619 | +100.0% | 0.02% | – | |
| OMIC | New | SINGULAR GENOMICS SYSTEMS IN | $33,000 | – | 16,215 | +100.0% | 0.01% | – |
| PASG | New | PASSAGE BIO INC | $31,000 | – | 22,661 | +100.0% | 0.01% | – |
| New | PARDES BIOSCIENCES INC | $33,000 | – | 19,757 | +100.0% | 0.01% | – | |
| HBIO | New | HARVARD BIOSCIENCE INC | $28,000 | – | 10,032 | +100.0% | 0.01% | – |
| New | INVIVYD INC | $22,000 | – | 14,967 | +100.0% | 0.01% | – | |
| BYSI | New | BEYONDSPRING INC | $20,000 | – | 10,833 | +100.0% | 0.01% | – |
| OVID | New | OVID THERAPEUTICS INC | $19,000 | – | 10,009 | +100.0% | 0.01% | – |
| New | LUMIRADX LTD | $14,000 | – | 15,621 | +100.0% | 0.01% | – | |
| CRTX | New | QUINCE THERAPEUTICS INC | $14,000 | – | 22,269 | +100.0% | 0.01% | – |
| New | POLARITYTE INC | $16,000 | – | 24,743 | +100.0% | 0.01% | – | |
| SYBX | New | SYNLOGIC INC | $16,000 | – | 20,961 | +100.0% | 0.01% | – |
| MBIO | New | MUSTANG BIO INC | $13,000 | – | 33,318 | +100.0% | 0.01% | – |
| OCX | New | ONCOCYTE CORP | $12,000 | – | 38,847 | +100.0% | 0.01% | – |
| NLTX | New | NEOLEUKIN THERAPEUTICS INC | $5,000 | – | 10,248 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.